
Lisa Faast, PharmD, discusses how to use technology to innovate within the pharmacy.

Lisa Faast, PharmD, discusses how to use technology to innovate within the pharmacy.

John Bucheit, PharmD, joined Drug Topics to discuss statins and nonstatins’ efficacy in treating cardiovascular disease.

Denise Kelley, PharmD, BCPS, FASHP, discussed the efficacy of medications designed to treat the progression of chronic kidney disease.

Kathryn Litten, PharmD, joined Drug Topics to discuss how pharmacists can counsel patients with metabolic dysfunction-associated steatotic liver disease.

See what’s trending in pharmacy with a preview of the Drug Topics November/December issue.

Scott Biggs, director of supplier services at IQVIA, discussed pharmacy trends within the industry and how pharmacists can stay ahead of them.

Researchers observed the use of a discrete event simulation using non-invasive tests for patients with nonalcoholic steatohepatitis.

A.J. Lipka discusses the impact of pharmacy-sponsored programming.

Researchers analyzed the expansion of HPV vaccination for mid-adults defined as people 26 years or older with increased HPV risk.

John Bucheit, PharmD, discussed lipid-lowering medications and how nonstatins can be beneficial for cardiovascular health.

In the most recent episode of Over the Counter, Jay Holloway, PharmD, AAHIVP, discussed advancements in HIV, especially regarding the role of pharmacists.

Researchers assessed the importance of a nutritious diet and the role pharmacists play in providing dietary management services.

Researchers observed data from 2010 to 2021 to better understand recent trends in US pharmacy closures and the specific pharmacy types that have been impacted.

TaQuina Warren, PharmD, owner of Focus Pharmacy in Smyrna, Delaware, explored the pharmacy profession from her perspective as an independent owner.

Researchers explored literature on the health benefits of the 4 main functional dietary components—prebiotics, probiotics, synbiotics, and postbiotics.

AMA released its 2024 Overdose Epidemic Report and presented key findings from the past year.

Drug Topics sat down with Laird Leavoy, President of American Pharmacies, to discuss the role leadership plays in the independent pharmacy industry.

On the most recent episode of Over the Counter, Steve Callahan, Senior Director of Advisory & Insights at MMIT, talked with us about biosimilars and the Inflation Reduction Act.

TaQuina Warren, PharmD, owner of Focus Pharmacy in Smyrna, Delaware, discussed her career journey and why pharmacists are so crucial to the interoperability of health care.

Researchers addressed vaccine effectiveness for individuals with direct household contacts that reported influenza.

Jay Holloway, PharmD, AAHIVP, Pharmacist with the AIDS Healthcare Foundation, joined Drug Topics to discuss the role pharmacists play in providing care for people with HIV.

Steve Callahan, Senior Director of Advisory & Insights at MMIT, discussed out-of-pocket costs and the impact biosimilars are predicted to have for patients in the future.

Jay Holloway, PharmD, AAHIVP, Pharmacist with the AIDS Healthcare Foundation, discussed the ongoing developments impacting patients with HIV and their prescription drugs.

Steve Callahan, Senior Director of Advisory & Insights at MMIT, sat down with Drug Topics to discuss industry trends behind biosimilars.

Researchers explored the disease activity of patients with axial spondylarthritis after various modifications to their diets.

Researchers aimed to address the associations between gout and ischemic events, specifically ischemic colitis.

Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, discussed the state of independent pharmacy.

Tom Utech, PharmD, CEO of iA, joined Drug Topics to discuss his company’s centralized pharmacy fulfillment solutions.

Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, joined Drug Topics to discuss his career journey.

Public health and infectious disease experts offered their perspectives on the 2024 US bird flu outbreak and its potential of becoming a greater public health crisis.